Send to

Choose Destination
J Neurointerv Surg. 2012 Jul;4(4):e16. doi: 10.1136/neurintsurg-2011-010019. Epub 2011 Jul 11.

Zygomatico-orbital intra-arterial melphalan infusion for intraocular retinoblastoma.

Author information

Department of Radiology and Biomedical Imaging, University California San Francisco, San Francisco, California, USA.


Retinoblastoma is a rare and curable malignancy affecting the pediatric population. For advanced stage intraocular retinoblastoma, enucleation remains the primary treatment modality, although the use of laser photocoagulation, cryotherapy, radiotherapy and chemotherapy are frequently used, particularly in the setting of bilateral disease. Intravenous chemotherapy is the long-standing method of delivery, but local administration (subtenon, intravitreal or intra-arterial) is gaining in popularity because of the reduced side effects related to systemic administration. Of these newer methods, intra-arterial infusion has demonstrated technical feasibility, few procedural complications and robust tumor response. A case is described where a collateral supply to the affected ophthalmic artery was via the zygomatico-orbital branch of the ipsilateral superficial temporal artery. Melphalan infusion was performed via this pathway without incident.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center